Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy

DSpace/Manakin Repository

Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy

Citable link to this page

 

 
Title: Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy
Author: Ayhan, Dilay Hazal; Tamer, Yusuf Talha; Akbar, Mohammed; Bailey, Stacey M.; Wong, Michael; Daly, Seth M.; Greenberg, David E.; Toprak, Erdal

Note: Order does not necessarily reflect citation order of authors.

Citation: Ayhan, Dilay Hazal, Yusuf Talha Tamer, Mohammed Akbar, Stacey M. Bailey, Michael Wong, Seth M. Daly, David E. Greenberg, and Erdal Toprak. 2016. “Sequence-Specific Targeting of Bacterial Resistance Genes Increases Antibiotic Efficacy.” PLoS Biology 14 (9): e1002552. doi:10.1371/journal.pbio.1002552. http://dx.doi.org/10.1371/journal.pbio.1002552.
Full Text & Related Files:
Abstract: The lack of effective and well-tolerated therapies against antibiotic-resistant bacteria is a global public health problem leading to prolonged treatment and increased mortality. To improve the efficacy of existing antibiotic compounds, we introduce a new method for strategically inducing antibiotic hypersensitivity in pathogenic bacteria. Following the systematic verification that the AcrAB-TolC efflux system is one of the major determinants of the intrinsic antibiotic resistance levels in Escherichia coli, we have developed a short antisense oligomer designed to inhibit the expression of acrA and increase antibiotic susceptibility in E. coli. By employing this strategy, we can inhibit E. coli growth using 2- to 40-fold lower antibiotic doses, depending on the antibiotic compound utilized. The sensitizing effect of the antisense oligomer is highly specific to the targeted gene’s sequence, which is conserved in several bacterial genera, and the oligomer does not have any detectable toxicity against human cells. Finally, we demonstrate that antisense oligomers improve the efficacy of antibiotic combinations, allowing the combined use of even antagonistic antibiotic pairs that are typically not favored due to their reduced activities.
Published Version: doi:10.1371/journal.pbio.1002552
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5025249/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:29407562
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters